Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma

NCT00960739 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Topotecan hydrochloride
PROCEDURE: Autologous hematopoietic stem cell transplantation
RADIATION: iobenguane I 131
RADIATION: total-body irradiation

Sponsor

Centre Oscar Lambret

Collaborators

[object Object]
[object Object]